7Baggers
 IO Biotech reports Q3 EPS (13c) vs (36c) last year  TipRanks Fri, 14 Nov 2025 23:24:24 GMT
 H.C. Wainwright Maintains IO Biotech(IOBT.US) With Hold Rating  富途牛牛 Fri, 14 Nov 2025 18:31:00 GMT
 IO Biotech, Inc. SEC 10-Q Report  TradingView Fri, 14 Nov 2025 14:13:04 GMT
 IO Biotech reports $8.4 mln Q3 net loss  MarketScreener Fri, 14 Nov 2025 13:17:01 GMT
 IO Biotech Announces Participation in Upcoming Investor Conferences  MarketScreener Wed, 12 Nov 2025 13:31:49 GMT
 IO Biotech presents new preclinical data at SITC 2025  Biostock Tue, 11 Nov 2025 08:17:57 GMT
 IO Biotech’s melanoma treatment shows improved survival rates By Investing.com  Investing.com Nigeria Sat, 08 Nov 2025 08:00:00 GMT
 io biotech presents pre-clinical data on io112, io170  TipRanks Fri, 07 Nov 2025 14:22:56 GMT
 IO Biotech presents preclinical data for new cancer vaccine candidates  Investing.com Fri, 07 Nov 2025 08:00:00 GMT
 io biotech shares face mounting pressure after regulatory setback  AD HOC NEWS Tue, 04 Nov 2025 13:05:05 GMT
 moderna takes on io biotech | apexonco - clinical trials news and analysis  Oncology Pipeline Fri, 31 Oct 2025 09:50:45 GMT
 published on: 2025-10-28 22:38:10  newser.com Wed, 29 Oct 2025 03:38:10 GMT
 layoff tracker: ferring will lay off 64 employees in new jersey  BioSpace Tue, 28 Oct 2025 07:00:00 GMT
 published on: 2025-10-28 01:28:56  newser.com Tue, 28 Oct 2025 06:28:56 GMT

IO Biotech, Inc.
(NASDAQ:IOBT) 

IOBT stock logo

IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops disruptive immune modulating anti-cancer therapies in Denmark. The company's lead product candidate, IO102-IO103, is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death...

Founded: 2014
CEO / Founder: Mai-Britt Zocca 
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends